1
TITLE: A phase i dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer  Full Text
AUTHORS: Coombes, RC; Cardoso, F; Isambert, N; Lesimple, T; Soulie, P; Peraire, C; Fohanno, V; Kornowski, A; Ali, T; Schmid, P;
PUBLISHED: 2013, SOURCE: Breast Cancer Research and Treatment, VOLUME: 140, ISSUE: 1
INDEXED IN: Scopus CrossRef